Oslo, Norway

Pci Biotech as


USPTO Granted Patents = 16

% Expired Patents = 37.5



Forward Citations = 8

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Anders Høgset (7 out of 8 patents)

silverMedal Kristian Berg (7 out of 14 patents)

bronzeMedal Anders Hogset (6 out of 6 patents)

4.  Lina Prasmickaite (4 out of 5 patents)

5.  Pål Johansen (3 out of 3 patents)

6.  Pal Kristian Selbo (3 out of 4 patents)

7.  Torunn E Tjelle (2 out of 5 patents)

8.  Jo Klaveness (1 out of 116 patents)

9.  Per Edvard Walday (1 out of 1 patent)

10.  Kristin Eivindvik (1 out of 1 patent)

11.  Mar Masson (1 out of 4 patents)

12.  Vivek S Gaware (1 out of 1 patent)

13.  Sigurd Bøe (1 out of 1 patent)

14.  Eivind Johannes Hovig (1 out of 3 patents)

15.  Anette Weyergang (1 out of 3 patents)


16 patents:

Company Overview
Pci Biotech AS is a biotechnology company based in Oslo, Norway, specializing in the development of innovative therapeutic solutions using its proprietary photochemical internalization technology. This platform enhances the delivery of various therapeutic agents, including nucleic acids and proteins, to target cells, significantly improving treatment efficacy. The company focuses on applications in oncology and other serious diseases, aiming to advance the field of targeted therapies through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#34 in Oslo

#99 in Norway

#37,831 in the World

Oslo, NO
Oslo, Norway
Forward Citations = 8

23 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pci Biotech as. Retrieved from https://idiyas.com/company/pci-biotech-as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…